Ganaxolone Safety Profile in CDKL5 Deficiency Disorder: Results From a Phase 3 Randomized, Double-blind, Placebo-Controlled Trial

被引：0
|
作者：
Pestana-Knight, E.
Rybak, E.
Grachev, I
Miller, I
机构：
来源：
ANNALS OF NEUROLOGY | 2021年 / 90卷
关键词：
Epilepsy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
244
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [31] Venlafaxine in fibromyalgia: Results of a randomized, placebo-controlled, double-blind trial.
    Zijlstra, TR
    Barendregt, PJ
    van De Laar, MAF
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S105 - S105
  • [32] Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials
    Huang, Zhaoyang
    Zhan, Shuqin
    Chen, Chunyan
    Zhang, Ruoxi
    Zhou, Yanling
    He, Jingjing
    Lin, Zhaocun
    Bao, Cungang
    Zhu, Shuangpeng
    Zhao, Jianjun
    Zhang, Shengan
    Jiang, Yu
    Wang, Yuping
    SLEEP, 2024, 47 (02)
  • [33] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
    McDonald, C.
    Wu, S.
    Gulati, S.
    Komaki, H.
    Ruiz-Garcia, M.
    Kostera-Pruszczyk, A.
    Vlodavets, D.
    Chae, J.
    Jong, Y.
    Karachunski, P.
    Statland, J.
    Lorentzos, M.
    Penematsa, V
    Chou, C.
    Lin, M.
    Werner, C.
    Trifillis, P.
    Gordon, G.
    Klein, M.
    NEUROMUSCULAR DISORDERS, 2022, 32
  • [34] Safety and Efficacy of Ataluren in nmDMD Patients from Study 041, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    McDonald, Craig M.
    Wu, Shiwen
    Gulati, Sheffali
    Komaki, Hirofumi
    Escobar, Rosa E.
    Kostera-Pruszczyk, Anna
    Vlodavets, Dmitry
    Chae, Jong-Hee
    Jong, Yuh-Jyh
    Karachunski, Peter
    Statland, Jeffrey
    Lorentzos, Michelle
    Penematsa, Vinay
    Chou, Connie
    Lin, Min
    Werner, Christian
    Trifillis, Panayiota
    Gordon, Gregory
    Koladicz, Karyn
    Mastrandrea, Nicholas
    Klein, Matthew
    NEUROLOGY, 2023, 100 (17)
  • [35] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [36] The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial
    Bose, K
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1999, 21 (03): : 209 - 213
  • [37] The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial
    McMurray, John J. V.
    Freeman, Mason W.
    Massaro, Joe
    Solomon, Scott
    Lock, Paul
    Riddle, Matthew C.
    Halvorsen, Yuan-Di C.
    DIABETES, 2020, 69
  • [38] Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries
    Buvat, Jacques
    Tesfaye, Fisseha
    Rothman, Margaret
    Rivas, David A.
    Giuliano, Francois
    EUROPEAN UROLOGY, 2009, 55 (04) : 957 - 968
  • [39] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [40] Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial
    Russo, Rossana Sanchez
    Gasperini, Serena
    Bubb, Gillian
    Neuman, Linda
    Sloan, Leslie S.
    Diaz, George A.
    Enns, Gregory M.
    ECLINICALMEDICINE, 2024, 68
12345